Administration of anti-FGF2 antibody marginally reduced (without statistical significance) the proportion of macrophages in the non-irradiated tumours, but did not alter the increase in CD11b+F4/80+ cells following irradiation (Fig. 8a–c). Here, FGF2 is linked to neoplasm.